HP and gastric cancer: In this study, we used the gastric cancer screening indicators, anti‐Hp antibody, CA724, CA19‐9, and CEA, to investigate the clinicopathological features of young patients with early gastric cancer, and to explore their predictive values in tumor recurrence, metastasis, and death of postoperative patients.